Subscribe To

Price Alert Latest News Economic Calendar News

IGXT / IntelGenx Technologies Corp. (IGXT) Q4 2022 Earnings Call Transcript

IntelGenx Technologies Corp. (OTCQB:IGXT) Q4 2022 Earnings Conference Call March 29, 2023 4:30 PM ET Company Participants Stephen Kilmer – Investor Relations Horst Zerbe – Chief Executive Officer Andre Godin – President and Chief Financial Officer Frank Pietrantonio – Director-Clinical Research Tommy Kenny – Vice President-Legal Affairs and Intellectual Property and General Counsel David Kideckel – Head-Corporate Development and Strategic Alliances Conference Call Participants Hugh Kelly – Private Investor Trevor Lee – Private Investor Lindsey Murphy – Private Investor Operator Greetings and welcome to the IntelGenx Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time all participants are in listen-only mode. Read More

Demo Live Account See Partner Details

Content Topics

Intelgenx

Technologies

Corp

IGXT

2022

Earnings

Call

igxt

Transcript

Stock

Posted: Mar 29 2023, 21:57

Author Name: Seeking Alpha

IGXT News

By GlobeNewsWire
November 2, 2023

IntelGenx to Report Third Quarter 2023 Financial Results on November 9, 2023 – Conference Call to Follow

SAINT LAURENT, Quebec, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceut

By Seeking Alpha
August 14, 2023

IntelGenx Technologies Corp. (IGXT) Q2 2023 Earnings Call Transcript

IntelGenx Technologies Corp. (OTCQB:IGXT) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Stephen Kilmer - Investor R

By Seeking Alpha
May 11, 2023

IntelGenx Technologies Corp. (IGXT) Q1 2023 Earnings Call Transcript

IntelGenx Technologies Corp. (OTCQB:IGXT) Q1 2023 Results Conference Call May 11, 2023 4:30 PM ET Company Participants Stephen Kilmer - Investor Relat

By Seeking Alpha
March 29, 2023

IntelGenx Technologies Corp. (IGXT) Q4 2022 Earnings Call Transcript

IntelGenx Technologies Corp. (OTCQB:IGXT) Q4 2022 Earnings Conference Call March 29, 2023 4:30 PM ET Company Participants Stephen Kilmer – Investor

By GlobeNewsWire
November 10, 2022

IntelGenx Reschedules Third Quarter 2022 Conference Call Due to Technical Issues Experienced Today by Webcast Vendor

SAINT LAURENT, Quebec, Nov. 10, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceut

By Seeking Alpha
May 12, 2022

IntelGenx Technologies' (IGXT) CEO Horst Zerbe on Q1 2022 Results - Earnings Call Transcript

IntelGenx Technologies Corp. (OTCQB:IGXT) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Horst Zerbe – Chief Executiv

By GlobeNewsWire
April 26, 2022

IntelGenx to Participate in the 2022 Bloom Burton & Co. Healthcare Investor Conference

SAINT LAURENT, Quebec, April 26, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceu

By Seeking Alpha
March 24, 2022

IntelGenx Technologies Corp. (IGXT) CEO Horst Zerbe on Q4 2021 Results - Earnings Call Transcript

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.